טוען...
Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency
OBJECTIVE: Prednisolone is used as glucocorticoid replacement therapy for adrenal insufficiency (AI). Recent data indicate that its use in AI is associated with low bone mineral density. Data on risk factors for cardiovascular disease in patients with AI treated with prednisolone are scarce, despite...
שמור ב:
| הוצא לאור ב: | Endocr Connect |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bioscientifica Ltd
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5148794/ https://ncbi.nlm.nih.gov/pubmed/27864317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-16-0081 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|